Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Initial insomnia, Injection site pain, Mammogram, Middle insomnia, Mobility decreased
Clinical narrative: DECREASED MOBILITY; DIFFICULTY INITIATING SLEEP; NOCTURNAL AWAKENING; NOCTURNAL PAIN; SPASMS; SWELLING; RIGHT ARM SEVERE PAIN; PAIN AT THE INJECTION SITE; WEAKNESS; This spontaneous report received from a patient via health care professional via a Regulatory Authority VAERS (Vaccine Adverse Event Reporting System) (VAERS ID 1856008) concerned a 54 year old female of an unspecified ethnicity. The patient's weight was 65.31 kilograms, and height was 162 centimeters. The patient's past medical history included: broken bone, joint injury, low back pain, back surgery, hernia repair, and cesarean section, and concurrent conditions included: arthritis, asthma, depression, insomnia, migraine, thyroid disease, non-smoker (no passive smoke exposure), postmenopausal, alcohol user (occasionally), caffeine user, latex allergy, and sulfa (sulfonamide antibiotics) allergy, and other pre-existing medical conditions included: The patient was not allergic to egg, neomycin and gelatin. The patient's family history includes father had cancer (unspecified) and diabetes mellitus, and mother and sister had cancer(unspecified). The patient was not pregnant at the time of vaccination. The patient was married and does not needed interpreter. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1), (suspension for injection, intramuscular, batch number: 1805025, expiry: UNKNOWN) dose was not reported, 1 total administered on 17-MAR-2021 to right deltoid for an unspecified indication. Age at time of vaccination 54 years old. No concomitant medications were reported.  On 17-MAR-2021, the patient experienced decreased mobility, difficulty initiating sleep, nocturnal awakening, nocturnal pain, spasms, swelling, right arm severe pain, pain at the injection site, and weakness (Dose number in series 1). it was reported that right arm pain occurs constantly and was stable. The pain was aching, sharp and piercing. The pain was aggravated by bending, lifting and movement. There was no reliving factors as per reported. On 25-MAY-2021, Laboratory data included: Mammogram (NR: not provided) not reported. On 15-DEC-2021, the patient received additional Pfizer Covid-19 vaccine (dose number in series 2), (form of admin, route of admin, and batch number were not reported), dose was not reported, administered for an unspecified indication. It was unknown whether patient had any adverse events following vaccination (dose number in series 2). On 25-MAR-2022 at 15:30, the patient visited the physician office. On 25-MAR-2022, Laboratory data included: Blood pressure (NR: not provided) 96/60 mmHg, Body mass index (NR: not provided) 24.72 kg/m2, Body surface area (NR: not provided) 1.72 m2, and Body temperature (NR: not provided) 98 F. Treatment medications included: levosalbutamol hydrochloride (inhale 3 millimliter by nebulization route every 8 hours for cough and shortness of breath, as needed). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain at the injection site, weakness, right arm severe pain, decreased mobility, difficulty initiating sleep, nocturnal awakening, nocturnal pain, spasms, and swelling. This report was non-serious.